Larimar Therapeutics (LRMR) Competitors $3.78 -0.18 (-4.55%) (As of 01:00 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LRMR vs. AVDL, ZYME, AVXL, COLL, PSTX, NUVB, AVBP, PAHC, QURE, and ETNBShould you be buying Larimar Therapeutics stock or one of its competitors? The main competitors of Larimar Therapeutics include Avadel Pharmaceuticals (AVDL), Zymeworks (ZYME), Anavex Life Sciences (AVXL), Collegium Pharmaceutical (COLL), Poseida Therapeutics (PSTX), Nuvation Bio (NUVB), ArriVent BioPharma (AVBP), Phibro Animal Health (PAHC), uniQure (QURE), and 89bio (ETNB). These companies are all part of the "pharmaceutical products" industry. Larimar Therapeutics vs. Avadel Pharmaceuticals Zymeworks Anavex Life Sciences Collegium Pharmaceutical Poseida Therapeutics Nuvation Bio ArriVent BioPharma Phibro Animal Health uniQure 89bio Avadel Pharmaceuticals (NASDAQ:AVDL) and Larimar Therapeutics (NASDAQ:LRMR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings. Do analysts recommend AVDL or LRMR? Avadel Pharmaceuticals presently has a consensus price target of $24.43, suggesting a potential upside of 138.79%. Larimar Therapeutics has a consensus price target of $20.43, suggesting a potential upside of 440.44%. Given Larimar Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Larimar Therapeutics is more favorable than Avadel Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avadel Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Larimar Therapeutics 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Does the MarketBeat Community favor AVDL or LRMR? Avadel Pharmaceuticals received 302 more outperform votes than Larimar Therapeutics when rated by MarketBeat users. However, 68.97% of users gave Larimar Therapeutics an outperform vote while only 66.02% of users gave Avadel Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAvadel PharmaceuticalsOutperform Votes34266.02% Underperform Votes17633.98% Larimar TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% Is AVDL or LRMR more profitable? Larimar Therapeutics has a net margin of 0.00% compared to Avadel Pharmaceuticals' net margin of -52.53%. Larimar Therapeutics' return on equity of -35.87% beat Avadel Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Avadel Pharmaceuticals-52.53% -93.34% -44.77% Larimar Therapeutics N/A -35.87%-32.37% Do insiders and institutionals hold more shares of AVDL or LRMR? 69.2% of Avadel Pharmaceuticals shares are owned by institutional investors. Comparatively, 91.9% of Larimar Therapeutics shares are owned by institutional investors. 4.8% of Avadel Pharmaceuticals shares are owned by company insiders. Comparatively, 3.5% of Larimar Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to AVDL or LRMR? In the previous week, Larimar Therapeutics had 9 more articles in the media than Avadel Pharmaceuticals. MarketBeat recorded 13 mentions for Larimar Therapeutics and 4 mentions for Avadel Pharmaceuticals. Avadel Pharmaceuticals' average media sentiment score of 1.02 beat Larimar Therapeutics' score of -0.37 indicating that Avadel Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avadel Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Larimar Therapeutics 0 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more volatility and risk, AVDL or LRMR? Avadel Pharmaceuticals has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Larimar Therapeutics has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Which has preferable earnings & valuation, AVDL or LRMR? Larimar Therapeutics has lower revenue, but higher earnings than Avadel Pharmaceuticals. Avadel Pharmaceuticals is trading at a lower price-to-earnings ratio than Larimar Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvadel Pharmaceuticals$138.16M7.14-$160.28M-$0.79-12.95Larimar TherapeuticsN/AN/A-$36.95M-$1.15-3.29 SummaryLarimar Therapeutics beats Avadel Pharmaceuticals on 12 of the 18 factors compared between the two stocks. Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Get Larimar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LRMR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LRMR vs. The Competition Export to ExcelMetricLarimar TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$238M$6.66B$5.18B$9.21BDividend YieldN/A3.00%5.12%4.30%P/E Ratio-3.2410.5787.6517.17Price / SalesN/A192.331,165.15121.16Price / CashN/A57.1643.2337.84Price / Book2.015.104.794.79Net Income-$36.95M$151.58M$120.46M$225.43M7 Day Performance-13.66%-1.95%-0.97%-0.12%1 Month Performance-39.45%-4.27%15.25%1.56%1 Year Performance-12.85%8.63%29.71%16.07% Larimar Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LRMRLarimar Therapeutics1.567 of 5 stars$3.78-4.5%$20.43+440.4%-7.5%$241.19MN/A-3.2930AVDLAvadel Pharmaceuticals2.6653 of 5 stars$10.10-2.0%$24.43+141.9%-26.5%$973.26M$138.16M-12.78154Positive NewsZYMEZymeworks2.8394 of 5 stars$13.97-1.2%$19.17+37.2%+45.3%$962.23M$62.20M-9.31290AVXLAnavex Life Sciences3.5871 of 5 stars$11.12+28.9%$43.00+286.7%+24.9%$942.93MN/A-22.2440Earnings ReportAnalyst ForecastNews CoverageGap UpHigh Trading VolumeCOLLCollegium Pharmaceutical3.8353 of 5 stars$29.14-1.9%$42.60+46.2%-3.0%$939.77M$599.25M12.56210PSTXPoseida Therapeutics3.7594 of 5 stars$9.44-0.1%$9.50+0.6%+182.1%$922.99M$150.86M-14.98260NUVBNuvation Bio2.3989 of 5 stars$2.64-1.5%$6.60+150.0%+79.2%$888.54M$2.16M-1.2260Analyst ForecastNews CoverageAVBPArriVent BioPharma0.7105 of 5 stars$26.14+0.2%$36.80+40.8%N/A$880.84MN/A0.0040Positive NewsPAHCPhibro Animal Health4.1758 of 5 stars$21.62-0.3%$20.50-5.2%+93.0%$875.68M$1.05B50.281,940Positive NewsQUREuniQure3.5705 of 5 stars$17.54+3.3%$33.88+93.1%+175.8%$854.95M$28.59M-3.54500Gap UpETNB89bio1.798 of 5 stars$7.98+0.5%$30.33+280.1%-26.7%$846.89MN/A-2.7440Positive News Related Companies and Tools Related Companies Avadel Pharmaceuticals Alternatives Zymeworks Alternatives Anavex Life Sciences Alternatives Collegium Pharmaceutical Alternatives Poseida Therapeutics Alternatives Nuvation Bio Alternatives ArriVent BioPharma Alternatives Phibro Animal Health Alternatives uniQure Alternatives 89bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LRMR) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Larimar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LRMR Stock Alerts